1. Jensen ML, Schousboe A, Ahring PK. Charge selectivity of the Cys-loop family of ligand-gated ion channels. J Neurochem. 2005; 92:217–225.
Article
2. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007; 47:699–729.
Article
3. Boulter J, Evans K, Goldman D, Martin G, Treco D, Heinemann S, Patrick J. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature. 1986; 319:368–374.
4. Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci USA. 1987; 84:7763–7767.
Article
5. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002; 3:102–114.
Article
6. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004; 74:363–396.
Article
7. Boorman JP, Groot-Kormelink PJ, Sivilotti LG. Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes. J Physiol. 2000; 529:565–577.
8. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron. 1990; 5:847–856.
9. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 1994; 79:705–715.
10. Gotti C, Hanke W, Maury K, Moretti M, Ballivet M, Clementi F, Bertrand D. Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur J Neurosci. 1994; 6:1281–1291.
11. Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C, Sakmann B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature. 1986; 321:406–411.
Article
12. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002; 3:102–114.
Article
13. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002; 96:67–202.
Article
14. Satoh E, Ishii T, Shimizu Y, Sawamura S, Nishimura M. The mechanism underlying the protective effect of the thearubigin fraction of black tea (Camellia sinensis) extract against the neuromuscular blocking action of botulinum neurotoxins. Pharmacol Toxicol. 2002; 90:199–202.
Article
15. Basu S, Chaudhuri T, Chauhan SP, Das Gupta AK, Chaudhury L, Vedasiromoni JR. The theaflavin fraction is responsible for the facilitatory effect of black tea at the skeletal myoneural junction. Life Sci. 2005; 76:3081–3088.
Article
16. Tong JJ. Mitochondrial delivery is essential for synaptic potentiation. Biol Bull. 2007; 212:169–175.
Article
17. Chiang HC, Iijima K, Hakker I, Zhong Y. Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions. FASEB J. 2009; 23:1969–1977.
18. Moustafa AM, Ahmed SH, Nabil ZI, Hussein AA, Omran MA. Extraction and phytochemical investigation of Calotropis procera: effect of plant extracts on the activity of diverse muscles. Pharm Biol. 2010; 48:1080–1190.
19. Re L, Barocci S, Capitani C, Vivani C, Ricci M, Rinaldi L, Paolucci G, Scarpantonio A, León-Fernández OS, Morales MA. Effects of some natural extracts on the acetylcholine release at the mouse neuromuscular junction. Pharmacol Res. 1999; 39:239–245.
Article
20. Lee BH, Jeong SM, Lee JH, Kim JH, Yoon IS, Lee JH, Choi SH, Lee SM, Chang CG, Kim HC, Han Y, Paik HD, Kim Y, Nah SY. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pretransmembrane domain I. Mol Cells. 2005; 20:69–73.
21. Lee BH, Lee JH, Yoon IS, Lee JH, Choi SH, Pyo MK, Jeong SM, Choi WS, Shin TJ, Lee SM, Rhim H, Park YS, Han YS, Paik HD, Cho SG, Kim CH, Lim YH, Nah SY. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2. Brain Res. 2007; 1161:1–10.
22. Lee BH, Choi SH, Shin TJ, Pyo MK, Hwang SH, Kim BR, Lee SM, Lee JH, Kim HC, Park HY, Rhim H, Nah SY. Quercetin enhances human α7 nicotinic acetylcholine receptor-mediated ion current through interactions with Ca(2+) binding sites. Mol Cells. 2010; 30:245–253.
Article
23. Lee BH, Choi SH, Shin TJ, Pyo MK, Hwang SH, Lee SM, Paik HD, Kim HC, Nah SY. Effects of quercetin on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Eur J Pharmacol. 2011; 650:79–85.
Article
24. Lee BH, Hwang SH, Choi SH, Shin TJ, Kang J, Lee SM, Nah SY. Quercetin inhibits alpha3beta4 nicotinic acetylcholine receptor-mediated ion currents expressed in xenopus oocytes. Korean J Physiol Pharmacol. 2011; 15:17–22.
25. Sine SM, Taylor P. Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem. 1982; 257:8106–8114.
Article
26. Heidmann T, Oswald RE, Changeux JP. Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983; 22:3112–3127.
Article
27. Arias HR. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol. 1996; 13:1–17.
Article
28. Gr⊘nlien JH, Ween H, Thorin-Hagene K, Cassar S, Li J, Briggs CA, Gopalakrishnan M, Malysz J. Importance of M2-M3 loop in governing properties of genistein at the α7 nicotinic acetylcholine receptor inferred from α7/5-HT3A chimera. Eur J Pharmacol. 2010; 647:37–47.
29. Zhang H, Toyohira Y, Ueno S, Shinohara Y, Itoh H, Furuno Y, Yamakuni T, Tsutsui M, Takahashi K, Yanagihara N. Dual effects of nobiletin, a citrus polymethoxy flavone, on catecholamine secretion in cultured bovine adrenal medullary cells. J Neurochem. 2010; 114:1030–1038.
Article